Alkermes Plc
NASDAQ:ALKS

Watchlist Manager
Alkermes Plc Logo
Alkermes Plc
NASDAQ:ALKS
Watchlist
Price: 29.08 USD -0.85%
Market Cap: 4.7B USD
Have any thoughts about
Alkermes Plc?
Write Note

EV/EBIT
Enterprise Value to EBIT

9.3
Current
-27.2
Median
4.1
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
9.3
=
Enterprise Value
4.1B USD
/
EBIT
436.5m USD
All Countries
Close
Market Cap EV/EBIT
IE
Alkermes Plc
NASDAQ:ALKS
4.7B USD 9.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -216 722.5
US
Abbvie Inc
NYSE:ABBV
316.8B USD 23.7
US
Amgen Inc
NASDAQ:AMGN
145.1B USD 30.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD 26
US
Gilead Sciences Inc
NASDAQ:GILD
113.2B USD 9.9
US
Epizyme Inc
F:EPE
94.1B EUR -501.6
AU
CSL Ltd
ASX:CSL
135.4B AUD 25.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 17.7
US
Seagen Inc
F:SGT
39.3B EUR -53.1
NL
argenx SE
XBRU:ARGX
34.3B EUR -76.4
EBIT Growth
IE
Alkermes Plc
NASDAQ:ALKS
Average EV/EBIT: 20.4
9.3
8%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 722.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
30.5
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.6 N/A
AU
CSL Ltd
ASX:CSL
25.6
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.4 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
10.2
2-Years Forward
EV/EBIT
9.6
3-Years Forward
EV/EBIT
9

See Also

Discover More